Cargando…
Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer
Buruli ulcer, an emerging tropical disease caused by Mycobacterium ulcerans (MU), is characterized by disfiguring skin necrosis and high morbidity. Relatively little is understood about the mode of transmission, pathogenesis, or host immune responses to MU infection. Due to significant reduction in...
Autores principales: | Hart, Bryan E., Hale, Laura P., Lee, Sunhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579011/ https://www.ncbi.nlm.nih.gov/pubmed/26393347 http://dx.doi.org/10.1371/journal.pntd.0004046 |
Ejemplares similares
-
Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy
por: Hart, Bryan E., et al.
Publicado: (2016) -
Cellular Immunity Confers Transient Protection in Experimental Buruli Ulcer following BCG or Mycolactone-Negative Mycobacterium ulcerans Vaccination
por: Fraga, Alexandra G., et al.
Publicado: (2012) -
On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012) -
The Incubation Period of Buruli Ulcer (Mycobacterium ulcerans Infection)
por: Trubiano, Jason A., et al.
Publicado: (2013) -
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
por: Yotsu, Rie R, et al.
Publicado: (2018)